Molina Healthcare Future Growth
Future criteria checks 3/6
Molina Healthcare is forecast to grow earnings and revenue by 13.5% and 9.1% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 23.4% in 3 years.
Key information
13.5%
Earnings growth rate
14.0%
EPS growth rate
| Healthcare earnings growth | 17.4% |
| Revenue growth rate | 9.1% |
| Future return on equity | 23.4% |
| Analyst coverage | Good |
| Last updated | 14 Jan 2025 |
Recent future growth updates
Here's What Analysts Are Forecasting For Molina Healthcare, Inc. (NYSE:MOH) After Its Third-Quarter Results
Oct 27
Revenue Beat: Molina Healthcare, Inc. Beat Analyst Estimates By 5.3%
Apr 26Recent updates
Returns On Capital Signal Tricky Times Ahead For Molina Healthcare (NYSE:MOH)
Jan 21Is Molina Healthcare (NYSE:MOH) A Risky Investment?
Nov 27Analyzing And Valuing Molina Healthcare As A Solid Company
Nov 13Here's What Analysts Are Forecasting For Molina Healthcare, Inc. (NYSE:MOH) After Its Third-Quarter Results
Oct 27Molina Healthcare Q3 Earnings Preview - Cost Fears Flare Up
Oct 18Returns On Capital Signal Tricky Times Ahead For Molina Healthcare (NYSE:MOH)
Oct 10Are Investors Undervaluing Molina Healthcare, Inc. (NYSE:MOH) By 48%?
Sep 11Does Molina Healthcare (NYSE:MOH) Deserve A Spot On Your Watchlist?
Aug 15Molina Healthcare: Health Insurer Selling For A Discount
Jul 25Molina Healthcare, Inc.'s (NYSE:MOH) Subdued P/E Might Signal An Opportunity
Jul 16Molina Healthcare (NYSE:MOH) Is Reinvesting At Lower Rates Of Return
May 27Molina Healthcare: Stock To Rise As Strategies Drive Strong Future Growth
May 06Revenue Beat: Molina Healthcare, Inc. Beat Analyst Estimates By 5.3%
Apr 26Molina Healthcare (NYSE:MOH) Seems To Use Debt Rather Sparingly
Apr 15Molina Healthcare, Inc.'s (NYSE:MOH) Popularity With Investors Is Clear
Apr 01Should You Be Adding Molina Healthcare (NYSE:MOH) To Your Watchlist Today?
Mar 18An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 35% Undervalued
Mar 04Molina Healthcare: Attractive Risk-Reward Calculus Over All Horizons
Jan 26Molina Healthcare Q3: Robust Growth Potential Yet Underrated Compared To Peers
Oct 30Molina Healthcare: Stable State Governments Contracts, And Undervalued
Sep 11Molina Healthcare: A Hidden Compounder In Managed Healthcare
Jul 17Molina Healthcare Is Still Appealing In The Face Of Medicaid Redetermination
Feb 21Molina Healthcare Non-GAAP EPS of $4.10 beats by $0.08, revenue of $8.22B beats by $350M
Feb 08Molina Healthcare takes $200M impairment on its leased space
Dec 29Molina Healthcare: Sacrificing Dividend For Growth Can Pay Off
Oct 20Molina initiated at overweight at JP Morgan on recent Medicaid contracts
Oct 04Molina Healthcare of New Mexico partners with Pyx Health
Sep 13Molina Healthcare reaches 52-week high; up 29% over last year
Aug 26Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 53,495 | 1,804 | N/A | N/A | 1 |
| 12/31/2026 | 47,115 | 1,611 | 1,666 | 11,709 | 11 |
| 12/31/2025 | 43,402 | 1,405 | 1,877 | 9,787 | 12 |
| 12/31/2024 | 40,394 | 1,255 | 1,265 | 7,092 | 12 |
| 9/30/2024 | 37,544 | 1,144 | 94 | 178 | N/A |
| 6/30/2024 | 36,084 | 1,063 | 179 | 254 | N/A |
| 3/31/2024 | 34,660 | 1,071 | 881 | 960 | N/A |
| 12/31/2023 | 33,003 | 1,091 | 1,578 | 1,662 | N/A |
| 9/30/2023 | 32,503 | 931 | 2,041 | 2,140 | N/A |
| 6/30/2023 | 31,835 | 916 | 1,341 | 1,445 | N/A |
| 3/31/2023 | 31,516 | 855 | 1,226 | 1,326 | N/A |
| 12/31/2022 | 31,101 | 792 | 682 | 773 | N/A |
| 9/30/2022 | 30,303 | 839 | 1,480 | 1,582 | N/A |
| 6/30/2022 | 29,435 | 752 | 1,691 | 1,789 | N/A |
| 3/31/2022 | 28,211 | 689 | 1,830 | 1,914 | N/A |
| 12/31/2021 | 26,984 | 659 | 2,042 | 2,119 | N/A |
| 9/30/2021 | 24,656 | 590 | 2,755 | 2,821 | N/A |
| 6/30/2021 | 22,602 | 632 | 2,144 | 2,202 | N/A |
| 3/31/2021 | 20,377 | 723 | 2,254 | 2,323 | N/A |
| 12/31/2020 | 18,375 | 673 | 1,824 | 1,898 | N/A |
| 9/30/2020 | 17,657 | 807 | 537 | 628 | N/A |
| 6/30/2020 | 16,999 | 797 | 946 | 1,028 | N/A |
| 3/31/2020 | 16,692 | 717 | 249 | 321 | N/A |
| 12/31/2019 | 16,340 | 737 | 377 | 434 | N/A |
| 9/30/2019 | 16,674 | 770 | 239 | 275 | N/A |
| 6/30/2019 | 17,054 | 792 | -508 | -472 | N/A |
| 3/31/2019 | 17,644 | 798 | -491 | -459 | N/A |
| 12/31/2018 | 18,144 | 707 | -344 | -314 | N/A |
| 9/30/2018 | 18,500 | 244 | -369 | -344 | N/A |
| 6/30/2018 | 18,921 | -50 | N/A | 446 | N/A |
| 3/31/2018 | 19,133 | -482 | N/A | 479 | N/A |
| 12/31/2017 | 19,445 | -512 | N/A | 804 | N/A |
| 9/30/2017 | 18,722 | -297 | N/A | 997 | N/A |
| 6/30/2017 | 18,216 | -158 | N/A | 1,067 | N/A |
| 3/31/2017 | 17,581 | 105 | N/A | 1,253 | N/A |
| 12/31/2016 | 17,022 | 52 | N/A | 673 | N/A |
| 9/30/2016 | 16,666 | 129 | N/A | 852 | N/A |
| 6/30/2016 | 15,759 | 133 | N/A | 755 | N/A |
| 3/31/2016 | 14,939 | 139 | N/A | 710 | N/A |
| 12/31/2015 | 13,537 | 143 | N/A | 1,125 | N/A |
| 9/30/2015 | 12,728 | 146 | N/A | 1,125 | N/A |
| 6/30/2015 | 11,620 | 116 | N/A | 1,473 | N/A |
| 3/31/2015 | 10,431 | 85 | N/A | 1,403 | N/A |
| 12/31/2014 | 9,373 | 62 | N/A | 1,060 | N/A |
| 9/30/2014 | 8,324 | 20 | N/A | 920 | N/A |
| 6/30/2014 | 7,564 | 11 | N/A | 537 | N/A |
| 3/31/2014 | 6,881 | 19 | N/A | 381 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MOH's forecast earnings growth (13.5% per year) is above the savings rate (2.6%).
Earnings vs Market: MOH's earnings (13.5% per year) are forecast to grow slower than the US market (15.1% per year).
High Growth Earnings: MOH's earnings are forecast to grow, but not significantly.
Revenue vs Market: MOH's revenue (9.1% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: MOH's revenue (9.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MOH's Return on Equity is forecast to be high in 3 years time (23.4%)
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 00:33 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Molina Healthcare, Inc. is covered by 34 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hua Ha | Baird |
| Andrew Mok | Barclays |
| Joshua Raskin | Barclays |